GoodRx/GDRX

$7.91

-5.27%
-
1D1W1MYTD1YMAX

About GoodRx

GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. The Company offers consumers free access for branded and generic medications, medical provider consultations via telehealth, and comprehensive healthcare research and information. The Company offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing and provides access to negotiated prices through its codes across the United States (the prescription transactions offering). These services are free to consumers. It also offers other healthcare products and services, including pharma manufacturer solutions, subscriptions and telehealth services. Its subscription offerings provide subscribers with added benefits and features, such as refill reminders, price alerts and other notifications.

Ticker

GDRX

Sector

Technology

Trading on

NASDAQ

Industry

Business Services

CEO

Scott Wagner

Employees

694

Headquarters

Santa monica, United States

GoodRx Metrics

BasicAdvanced
$3.3B
Market cap
-
P/E ratio
-$0.02
EPS
1.44
Beta
-
Dividend rate

What the Analysts think about GoodRx

Analyst Ratings

Majority rating from 20 analysts.
Hold

Price Targets

Average projection from 16 analysts.
4.3% upside
High $14.00
Low $5.00
$7.91
Current price
$8.25
Average price target

GoodRx Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-13.12% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$196.6M
9.28%
Net income
$-25.8M
-32.81%
Profit margin
-13.12%
-38.52%

GoodRx Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 18.52%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.07
$0.07
$0.06
$0.08
-
Expected
$0.06
$0.06
$0.06
$0.07
$0.07
Surprise
25.28%
15.77%
3.81%
18.52%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell GoodRx stock

Buy or sell GoodRx stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing